Form SC 13G - Statement of acquisition of beneficial ownership by individuals
14 Fevereiro 2024 - 1:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities
Exchange Act of 1934
(Amendment No. )*
Sharps Technology, Inc.
|
(Name of Issuer) |
Common Stock, $0.0001 par value
|
|
(Title of Class of Securities) |
82003F101
|
|
(CUSIP Number) |
|
December 31, 2023 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
x Rule
13d-1(b)
o Rule
13d-1(c)
o Rule
13d-1(d)
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. 82003F101
|
SCHEDULE 13G
|
Page 2
of 6 Pages
|
|
|
|
|
|
1
|
NAME OF REPORTING PERSONS
Walleye Capital LLC
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
|
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Minnesota
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
1,000,026
|
6
|
SHARED VOTING POWER
0
|
7
|
SOLE DISPOSITIVE POWER
1,000,026
|
8
|
SHARED DISPOSITIVE POWER
0
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,000,026
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
o
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.55%
|
12
|
TYPE OF REPORTING PERSON
IA
|
CUSIP
No. 82003F101
|
SCHEDULE 13G
|
Page 3
of 6 Pages
|
Item 1. | | (a) Name of Issuer |
Sharps Technology, Inc.
Item 1. | | (b) Address of Issuer’s Principal
Executive Offices |
105 Maxess Road
Melville, New York 11747
Item 2. | | (a, b, c) Names of Person Filing, Address
of
Principal
Business Office, Citizenship: |
Walleye
Capital LLC, a Minnesota limited liability company
315 Park Ave. South
New York, NY 10010
Item 2. | | (d) Title of Class of Securities |
Common Stock, $0.0001 par value
82003F101
CUSIP No. 82003F101
|
SCHEDULE 13G
|
Page 4
of 6 Pages
|
|
Item 3. If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|
(a) |
o |
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
|
|
(b) |
¨ |
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
|
|
(c) |
¨ |
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
|
|
(d) |
¨ |
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); |
|
|
(e) |
x |
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
(f) |
¨ |
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
|
|
(g) |
¨ |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
|
|
(h) |
¨ |
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
|
(i) |
¨ |
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3); |
|
|
(j) |
¨ |
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); |
|
|
(k) |
¨ |
A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J),
please specify the type of institution: |
|
|
|
|
CUSIP
No. 82003F101
|
SCHEDULE 13G
|
Page
5 of 6 Pages
|
Item
4. Ownership
Information
with respect to the Reporting Person’s ownership of the Common Stock, $0.0001 par value as of December 31, 2023, is incorporated by reference
to items (5) - (9) and (11) of the cover page for the Reporting Person.
The
amount beneficially owned by the Reporting Person is determined based on 15,274,457 shares of Common Stock, $0.0001 par value,
outstanding as of November 14, 2023.
Sharps Technology (NASDAQ:STSS)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Sharps Technology (NASDAQ:STSS)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia Segunda, 17 de Junho de 2024 (1 dia atrás) • GlobeNewswire Inc. |
Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18 Sexta, 14 de Junho de 2024 (4 dias atrás) • GlobeNewswire Inc. |
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility Quinta, 13 de Junho de 2024 (5 dias atrás) • GlobeNewswire Inc. |
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit Quarta, 5 de Junho de 2024 (2 semanas atrás) • GlobeNewswire Inc. |
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S. Sexta, 31 de Maio de 2024 (3 semanas atrás) • GlobeNewswire Inc. |
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S. Quinta, 30 de Maio de 2024 (3 semanas atrás) • GlobeNewswire Inc. |
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes Terça, 28 de Maio de 2024 (3 semanas atrás) • GlobeNewswire Inc. |
Form 8-K - Current report Sexta, 8 de Março de 2024 (3 meses atrás) • Edgar (US Regulatory) |
Form 8-K - Current report Quinta, 7 de Março de 2024 (3 meses atrás) • Edgar (US Regulatory) |
Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems Quinta, 7 de Março de 2024 (3 meses atrás) • GlobeNewswire Inc. |
Form 4 - Statement of changes in beneficial ownership of securities Quarta, 21 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory) |
Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia Quarta, 21 de Fevereiro de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Mais Notícias de Sharps Technology Inc
Parece que você não está logado. Clique no botão abaixo para se logar e ver seu histórico recente.